CYCLACEL PHARMACEUTICALS INC's ticker is CYCCP and the CUSIP is 23254L207. A total of 1 filers reported holding CYCLACEL PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $89,000 | +15.6% | 13,253 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $77,000 | -16.3% | 13,253 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $92,000 | -6.1% | 13,253 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $98,000 | +19.5% | 13,253 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $82,000 | -1.2% | 13,253 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $83,000 | +1.2% | 13,253 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $82,000 | -8.9% | 13,253 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $90,000 | +8.4% | 13,253 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $83,000 | +9.2% | 13,253 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $76,000 | +46.2% | 13,253 | 0.0% | 0.00% | – |
| Q4 2015 | $52,000 | -16.1% | 13,253 | 0.0% | 0.00% | -100.0% |
| Q3 2015 | $62,000 | -27.1% | 13,253 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $85,000 | -1.2% | 13,253 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $86,000 | +4.9% | 13,253 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $82,000 | -20.4% | 13,253 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $103,000 | -4.6% | 13,253 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $108,000 | -4.4% | 13,253 | 0.0% | 0.00% | 0.0% |
| Q1 2014 | $113,000 | -41.5% | 13,253 | -36.8% | 0.00% | -66.7% |
| Q4 2013 | $193,000 | +9.0% | 20,979 | 0.0% | 0.00% | 0.0% |
| Q3 2013 | $177,000 | +17.2% | 20,979 | 0.0% | 0.00% | 0.0% |
| Q2 2013 | $151,000 | – | 20,979 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |